Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Henan Lingrui Pharmaceutical Co Ltd and Subsidiary to Sell Shares of Beijing-based Company


Thursday, 29 Aug 2013 12:00pm EDT 

Henan Lingrui Pharmaceutical Co Ltd announced that it will sell a 60% stake in a Beijing-based sanitary material company, for RMB 11,388,000 to the Company's top shareholder. The Company's wholly owned subsidiary, a Henan-based investment company will sell a 40% stake in the Beijing-based company to the Company's top shareholder, for RMB 7,592,000. After the transaction, the Company will hold no stake in the Beijing-based company. 

Company Quote

9.51
0.02 +0.21%
2:23am EDT